Actively Recruiting
Do Intravaginal Devices Reduce Urinary Incontinence in Female Runners?
Led by University of Ottawa · Updated on 2024-12-17
90
Participants Needed
1
Research Sites
124 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
More than one in five females experience the embarrassment and shame of urine leakage while exercising and this urinary incontinence (UI) is a substantial barrier to exercise. As many as one in three females with UI report that they limit their physical activity due to incontinence: 11.6% by not exercising at all, 11.3% by exercising less and 12.4% by changing the type of exercise they perform. It is imperative to look for alternatives to manage this condition, as it is a key reason why females abandon the very physical exercise that is necessary to maintain or improve their physical and mental health and their quality of life. While there is Grade A evidence for pelvic floor muscle training and some evidence for intravaginal pessaries to reduce symptoms of UI in general female populations, no study has evaluated the impact of conservative interventions specifically on UI experienced predominantly during running.
CONDITIONS
Official Title
Do Intravaginal Devices Reduce Urinary Incontinence in Female Runners?
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Female runners aged 18 years and older
- Running at least twice weekly for a minimum of 10 kilometers per week at a speed of 6 km/h or higher
- Running this amount for at least 6 months prior to the study
- Regularly experiencing urine leakage during running at least once per week
- Commitment to maintain the same running amount during the study period
You will not qualify if you...
- Having risk factors related to exercise
- Experiencing pain or musculoskeletal injury at screening
- History of urogenital surgery
- Symptoms of the female athlete triad
- Known neurological disorders such as stroke or multiple sclerosis
- Pregnancy or childbirth within the previous year
- Unable to run on a treadmill for 38 minutes with a moderately full bladder
- Body Mass Index (BMI) of 30 or higher
- Pelvic organ prolapse grade 2 or greater
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
McLean Function Measurement Lab
Ottawa, Ontario, Canada, K1S 1S2
Actively Recruiting
Research Team
L
Linda McLean
CONTACT
S
Sabine Vesting
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here